Detalles de la búsqueda
1.
Anti-HLA-B7/HLA-B44 strong cross immunoreactivity observed in flow cytometry HLA-B27 immunotyping.
Cytometry A
; 105(5): 376-381, 2024 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38379087
2.
Monitoring of Both Humoral and Cellular Immunities Could Early Predict COVID-19 Vaccine Efficacy Against the Different SARS-CoV2 Variants.
J Clin Immunol
; 43(1): 31-45, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36006568
3.
FRET causing misleading signal from fluorescein excited by the violet laser in flow cytometry.
Cytometry A
; 103(9): 732-735, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37552188
4.
Validation Study of a New Random-Access Chemiluminescence Immunoassay Analyzer i-TRACK10® to Monitor Infliximab and Adalimumab Serum trough Levels and Anti-Drug Antibodies.
Int J Mol Sci
; 23(17)2022 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36076966
5.
Adalimumab and anti-adalimumab LISA-TRACKER immunoassays performance criteria for therapeutic drug monitoring of adalimumab-amgen biosimilar (ABP501).
BMC Immunol
; 22(1): 81, 2021 12 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34953484
6.
Fluorescent energy transfer causing misleading signal in multicolor flow cytometry.
Cytometry A
; 99(11): 1102-1106, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33826227
7.
Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial.
Gut
; 69(7): 1206-1212, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31980448
8.
Comparison of Immunoassays for Measuring Serum Levels of Golimumab and Antibodies Against Golimumab in Ulcerative Colitis: A Retrospective Observational Study.
Ther Drug Monit
; 41(4): 459-466, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30817702
9.
Evaluation of Infliximab and Anti-infliximab LISA-TRACKER Immunoassays for the Therapeutic Drug Monitoring of SB2 Infliximab Biosimilar.
Ther Drug Monit
; 40(6): 749-753, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30439790
10.
Comparison of Point-of-Care and Classical Immunoassays for the Monitoring Infliximab and Antibodies Against Infliximab in IBD.
Dig Dis Sci
; 63(10): 2714-2721, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29948562
11.
Basophil activation test: Implementation and standardization between systems and between instruments.
Cytometry A
; 91(3): 261-269, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28281330
12.
Major influence of CD4 count at the initiation of cART on viral and immunological reservoir constitution in HIV-1 infected patients.
Retrovirology
; 13(1): 44, 2016 06 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-27363286
13.
Prior COVID-19 Immunization Does Not Cause IgA- or IgG-Dependent Enhancement of SARS-CoV-2 Infection.
Vaccines (Basel)
; 11(4)2023 Mar 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37112685
14.
Development of Antibodies to Ustekinumab Is Associated with Loss of Response in Patients with Inflammatory Bowel Disease.
J Clin Med
; 12(10)2023 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37240501
15.
Human leukocyte antigen-B27 typing by flow cytometry: Comparison of three CE-IVD methods.
Cytometry B Clin Cytom
; 2022 Nov 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36448700
16.
Increased Immunity against the Oral Germs Porphyromonas gingivalis and Prevotella intermedia in Different Categories of Juvenile Idiopathic Arthritis.
Biomedicines
; 10(10)2022 Oct 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36289875
17.
Swapping Versus Dose Optimization in Patients Losing Response to Adalimumab With Adequate Drug Levels.
Inflamm Bowel Dis
; 28(5): 720-727, 2022 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34405867
18.
Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients.
EBioMedicine
; 80: 104077, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35644124
19.
Human peripheral basophils extended phenotype shows a high expression of CD244 immuno-regulatory receptor.
J Immunol Methods
; 492: 112951, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33493550
20.
Early detection of anti-drug antibodies during initiation of anti-tumour necrosis factor therapy predicts treatment discontinuation in inflammatory bowel disease.
Aliment Pharmacol Ther
; 53(11): 1190-1200, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33872404